RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in RAPT Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- −8 vs. Q2 2024
- Shares held
- 29.8M
- +430.7K (+1.5%) vs. Q2 2024
- Total value
- $59.9M
- −$29.7M (−33.1%) vs. Q2 2024
- New holders
- 11
- 28 more added
- Sold out
- 19
- 26 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RAPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 106 | $1.02B |
| Q3 2025 | 65 | $428.0M |
| Q2 2025 | 50 | $135.6M |
| Q1 2025 | 92 | $160.0M |
| Q4 2024 | 91 | $199.5M |
| Q3 2024 | 94 | $59.9M |
| Q2 2024 | 103 | $97.0M |
| Q1 2024 | 122 | $287.2M |
| Q4 2023 | 109 | $869.3M |
| Q3 2023 | 96 | $577.8M |
| Q2 2023 | 98 | $636.7M |
| Q1 2023 | 106 | $610.5M |
| Q4 2022 | 95 | $634.7M |
| Q3 2022 | 98 | $721.0M |
| Q2 2022 | 85 | $542.7M |
| Q1 2022 | 85 | $616.1M |
| Q4 2021 | 99 | $1.02B |
| Q3 2021 | 106 | $817.8M |
| Q2 2021 | 109 | $846.6M |
| Q1 2021 | 78 | $468.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding RAPT Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Verition Fund Management LLC | 0 | $0 | 0.00% | −55,825−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −53,993−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −36,654−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −35,480−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −17,421−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −10,546−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −8,697−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −4,599−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −914−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −257−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |